Original articleMycobacterium xenopi infection and aspergilloma
References (7)
Aspergilloma and residual tuberculous cavities—the results of a resurvey
Tubercle
(1970)- et al.
Pulmonary mycetoma following Mycobacterium kansasii infection
Arch Intern Med
(1985) - et al.
Clinical review of pulmonary disease caused by Mycobacterium xenopi
Thorax
(1983)
Cited by (22)
Pulmonary aspergillosis complicating atypical mycobacterial infection in two patients suffering from chronic obstructive pulmonary disease
2012, Revue des Maladies RespiratoiresClinical presentation of pulmonary mycetoma in HIV-infected patients
2002, ChestCitation Excerpt :A chest radiograph and CT scans for one such patient are shown in Figure 3. Pulmonary mycetomas occur most commonly in preexisting tuberculous cavities, but they have also been described in lungs that have been destroyed by sarcoidosis,16 bronchiectasis,17 lung abscess,17 neoplasms,18 pulmonary infarcts,19 nontuberculous mycobacteria,20 various mycoses,2122 and PCP.1013 HIV-infected patients are at increased risk for several of these conditions (TB, bacterial and fungal infections, and PCP).
Pulmonary resection for Mycobacterium xenopi pulmonary infection
2001, Annals of Thoracic SurgeryCitation Excerpt :Therefore, resection seems necessary to obtain reliable cure and prevent relapse in patients with M xenopi pulmonary disease who can tolerate resection, especially those with cavitary disease. Other arguments support early operation in patients with M xenopi pulmonary disease: more than 70% of such patients subsequently develop aspergilloma, a proportion much higher than in other NTM diseases [21]. Moreover, unsuspected lung cancer was diagnosed on surgical specimens in 2 patients in our series operated on with a therapeutic intent [22].
Concomitant or sequential pulmonary infection with non-tuberculous mycobacteria and Aspergillus
2023, International Journal of Tuberculosis and Lung DiseaseReview of the international clinical practice guidelines for the treatment of lung infections caused by non-tuberculous mycobacteria
2021, Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia